The university is 30 years old.Discover its past and present.Help build its future.
14 February 2017
Find out about bachelor's degrees, postgraduate courses and all the educational courses offered by the UdG.
Teaching is concentrated in the faculties and schools, and the departments deal with research, which is also conducted by institutes and chairs, at the same time responsible for knowledge promotion.
The master provides the option of doing in-company internship placements (optional subject worth 6 ECTS credits in the second semester), with businesses, organisations, or high-quality research groups in the molecular biology and biomedicine sectors.
To request a place you need to access the company placement website platform
If you have any queries about internships, please email practiques.fc@udg.edu or call +34 972 419 575
GROUP F The assessment takes place in February (report submission deadline: 9 January 2026).
GROUP J The assessment takes place in June (report submission deadline: 12 June 2026).
GROUP S The assessment will take place in September (report submission deadline: 1 September 2026).
How to submit the report (before the submission deadline for each call):
gives students the opportunity to take an optional practical subject (Practical Module) worth 6 ECTS credits in one of the UdG or IDIBGI's excellent research groups.
The subject aims to train students in different basic experimental techniques in a molecular biology laboratory, and their application in the fields of biomedicine and biotechnology.
The course is highly recommended for students who have completed a bibliographic or review-based bachelor’s thesis.Although these are two different and independent subjects, it is possible to combine the practical module (as an initial training in laboratory techniques) with the master's thesis in the same laboratory, in order to extend the training period.
To apply for the practical module you need:
The Practical Module is assessed by the tutor using the rubric .
https://www.udg.edu/ca/g1rupsrecerca/translab
o Study: longitudinal clinical study among cohorts of healthy pregnant women and newborns included in the health care areas in Girona and at the Dr. Josep Trueta University Hospital in Girona.
o Objective: To analyse epigenetic marks in genes imprinted on the placenta and umbilical cord as predictors of postnatal growth and susceptibility to developing metabolic and cardiovascular diseases in adulthood.
o Methods: clinical, biochemical, imaging and in vivo studies (development of animal models for the analysis of epigenetic markers in the metabolic regulation in tissues - liver and adipose tissue - of the offspring).
o Funding: line of research consolidated with the FIS PI13/01257, PI16/01335 and PI19/00451 projects.
o Study: studies and clinical trials in adolescents with PCOS and girls with precocious puberty included in the health care areas in Girona, and at the Dr. Josep Trueta University Hospital in Girona.
o Objectives: 1) to develop a new effective metabolic treatment for PCOS; 2) to determine whether metabolic treatment for PCOS can slow down accelerated maturation in girls with advanced puberty; 3) to study epigenetic factors related to pubertal evolution in girls with precocious puberty.
o Methods: Observational studies and clinical drug trials in adolescents with PCOS and girls with precocious puberty.and metabolic-epigenetics of cancer and ageing.
o Understanding the role of metabolism in the tumourogenic process
o Metabolic mechanisms of cancer drug resistance
o Identification of metabolic vulnerabilities as drug targets for the treatment of cancer
o Metabolomics and metabolic markers for early detection and clinical monitoring of initiation, progression and therapeutic resistance
o Metabolo-epigenetics: Molecular aspects, computational modelling and the development of therapeutics for precision medicine
o The role of autophagy and mitochondria in the generation of tumour stem cells
o Mitochondrial dynamics as a therapeutic target for cancer treatment
o Discovery and molecular characterisation of natural biocompounds with anti-cancer properties o Pre-clinical development and clinical evaluation of anti-tumour drugs based on natural biocompounds
o Identification of the metabolites and metabolic nodes essential for the regulation of immune checkpoints in cancer cells.
o Metabolic and dietary interventions to increase the efficacy of immune checkpoint inhibitors (ICIs).
o Computational development and preclinical validation of new therapeutic strategies based on metabolo-immunotherapy using an in silico clinical trial platform
o Conceptual frameworks, stochastic tools and laboratory validation of metabolic and metabolo-epigenetic models of cancer and ageing.
These options will vary depending on the lines of research being studied in the corresponding academic year, potentially extending to groups of research that do not feature in this list.
Choose which types of cookies you accept which the University of Girona can store in your browser.
Those that are essential for enabling your connection.There is no option for disabling them, as they are necessary for the functioning of the website.
These enable your options to be remembered (for example language or region you are accessing from), to provide you with advanced services.
They provide statistical information and enable improved services.We use Google Analytics cookies which you can deactivate by installing this plugin.
To offer advertising contents relating to the interests of users, either directly, or through third parties (“adservers”). These must be activated if you wish to see the YouTube videos uploaded to the University of Girona’s website.
The University of Girona website uses its own and third-party cookies for technical and analytical purposes.To manage them use the manager.If you would like further information, please access our Cookies Policy.